MeSH tree: C22
Early-season tick bites have been driving more people to emergency rooms since 2017, and Virginia, along with several other northeastern states, is in the bull's-eye.
May 11, 2026
0
7
Following the rise in Mpox cases, particularly in countries where the disease had not traditionally been observed, the World Health Organization (WHO) declared a Public Health Emergency of International Concern in June 2022 ...
May 1, 2026
0
5
Up-close tick encounters are nothing new to Peter Krause. As a tick-borne disease researcher, he's conducted fieldwork where these parasites live. After one trip to Block Island, off the coast of Rhode Island where ticks ...
Apr 23, 2026
0
5
The federal government's disease-tracking agency has paused its diagnostic testing for rabies, monkeypox and a number of other infectious diseases.
Apr 2, 2026
0
6
A new study led by investigators from Mass General Brigham and Yale School of Public Health reveals that red blood cell exchange transfusion (ET) may provide critical benefits for patients hospitalized with severe babesiosis. ...
Mar 30, 2026
0
8
Tick-borne diseases are on the rise in the northeastern US, with many ticks carrying more than one pathogen, reports a recent analysis published in Ecosphere by researchers at Cary Institute of Ecosystem Studies and the SUNY ...
Mar 11, 2026
0
17
People affected by human immunodeficiency virus (HIV), which causes AIDS, did not develop more severe forms of mpox than HIV-negative people during the multiregional outbreak of this disease that occurred in Spain in 2022. ...
Mar 11, 2026
0
4
Since its first documentation in 1976, there have been more than three dozen outbreaks of Ebola virus disease in Central and West Africa, the largest of which resulted in the deaths of more than 11,000 people between 2013 ...
Mar 11, 2026
0
9
An antibody test for the infectious disease mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting. The test, an IgG ELISA ...
Mar 9, 2026
0
11
An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox compared with placebo, ...
Mar 2, 2026
0
8
